What were Acutaas Chemicals Ltd's latest quarterly results?
Acutaas Chemicals Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +112.7% (stable)
- Revenue Growth YoY: +40.6%
- Operating Margin: 42.0% (volatile)
Acutaas Chemicals Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +39.0%Average12w Streak
In , Acutaas Chemicals Ltd (Pharma - API & CRAMS) is outperforming Nifty 500 with +39.0% relative strength. Fundamentals: Average. On a 12-week streak.
Acutaas Chemicals Ltd Key Facts
- PE Ratio
- 62.8x
- Price/Book
- 11.51x
- Market Cap
- ₹22,386 Cr
- PAT Growth YoY
- +113%
- Revenue Growth YoY
- +41%
- OPM
- 42.0%
- RS vs Nifty 500
- +39.0%
Strong Opportunity
What's Happening
💎PE falling while earnings hold — value emerging
💪Debt reduced 78% YoY — balance sheet strengthening
👔Promoter stake down 3.3% this quarter
🌐FII stake increased 3.0% this quarter
🏛️DII accumulation — stake up 2.7%
💰Trading 22% below estimated fair value
Key Numbers
PAT Growth YoY
+113%
Stable
Revenue YoY
+41%
Stable
Operating Margin
42.0%
+1400 bps YoY
PE Ratio
62.8
PEG Ratio
1.61
EV/EBITDA
41.9
Current Price
₹2,734
Dividend Yield
0.05%
Fundamental Score
55/100
Average
3Y PAT CAGR
+62%
Market Cap
22.4K Cr
Valuation
Undervalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Acutaas Chemicals Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +41% | +29% | Stable |
| PAT (Net Profit) | +113% | +62% | Stable |
| OPM | 42.0% | +1400 bps | Volatile |
Other Top Pharma - API & CRAMS Stocks Beating Nifty 500
Frequently Asked Questions: Acutaas Chemicals Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Acutaas Chemicals Ltd's profit growing or declining?
Acutaas Chemicals Ltd's profit is growing with an stable trend.
- PAT Growth YoY: +112.7% (latest quarter)
- PAT Growth QoQ: +26.4% (sequential)
- 3-Year PAT CAGR: +62.5%
- Trend: Stable — consistent growth pattern
What is Acutaas Chemicals Ltd's revenue growth trend?
Acutaas Chemicals Ltd's revenue growth trend is stable.
- Revenue Growth YoY: +40.6%
- Revenue Growth QoQ: +10.2% (sequential)
- 3-Year Revenue CAGR: +29.5%
How is Acutaas Chemicals Ltd's operating margin trending?
Acutaas Chemicals Ltd's operating margin is volatile.
- Current OPM: 42.0%
- OPM Change YoY: +14.0% basis points
- OPM Change QoQ: +4.0% basis points
What is Acutaas Chemicals Ltd's 3-year profit and revenue CAGR?
Acutaas Chemicals Ltd's long-term compounding rates
- 3-Year Profit CAGR: +62.5%
- 3-Year Revenue CAGR: +29.5%
Is Acutaas Chemicals Ltd's growth accelerating or decelerating?
Acutaas Chemicals Ltd's earnings growth is stable with positive momentum on a sequential basis.
- YoY Acceleration: 0.0% bps
- Sequential Acceleration: -20.8% bps
What is Acutaas Chemicals Ltd's trailing twelve month (TTM) performance?
Acutaas Chemicals Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹356 Cr
- TTM PAT Growth: +100.0% YoY
- TTM Revenue: ₹1,000 Cr
- TTM Revenue Growth: +33.0% YoY
- TTM Operating Margin: 35.7%
Is Acutaas Chemicals Ltd overvalued or undervalued?
Acutaas Chemicals Ltd appears undervalued based on our fair value analysis.
- Valuation Signal: Undervalued
- Current PE: 62.8x
- Price-to-Book: 13.5x
What is Acutaas Chemicals Ltd's current PE ratio?
Acutaas Chemicals Ltd's current PE ratio is 62.8x.
- Current PE: 62.8x
- Market Cap: 22.4K Cr
- Dividend Yield: 0.05%
How does Acutaas Chemicals Ltd's valuation compare to its history?
Acutaas Chemicals Ltd's current PE is 62.8x.
- Current PE: 62.8x
- Valuation Assessment: Undervalued
What is Acutaas Chemicals Ltd's price-to-book ratio?
Acutaas Chemicals Ltd's price-to-book ratio is 13.5x.
- Price-to-Book (P/B): 13.5x
- Book Value per Share: ₹202
- Current Price: ₹2734
Is Acutaas Chemicals Ltd a fundamentally strong company?
Acutaas Chemicals Ltd is rated Average with a fundamental score of 55.36/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +40.6% (10% weight)
- PAT Growth YoY: +112.7% (10% weight)
- PAT Growth QoQ: +26.4% (10% weight)
- Margins stable (10% weight)
- PEG Ratio: 1.6x vs sector median (15% weight)
- EV/EBITDA: 41.9x vs sector median (15% weight)
Is Acutaas Chemicals Ltd debt free?
Acutaas Chemicals Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹36 Cr
What is Acutaas Chemicals Ltd's return on equity (ROE) and ROCE?
Acutaas Chemicals Ltd's return ratios over recent years
- FY2024: ROCE 16.0%
- FY2025: ROCE 20.0%
- FY2026: ROCE 32.0%
Is Acutaas Chemicals Ltd's cash flow positive?
Acutaas Chemicals Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹292 Cr
- Free Cash Flow (FCF): ₹26 Cr
- CFO/PAT Ratio: 82% (strong cash conversion)
What is Acutaas Chemicals Ltd's dividend yield?
Acutaas Chemicals Ltd's current dividend yield is 0.05%.
- Dividend Yield: 0.05%
- Current Price: ₹2734
Who holds Acutaas Chemicals Ltd shares — promoters, FII, DII?
Acutaas Chemicals Ltd's shareholding pattern (Mar 2026)
- Promoters: 32.7%
- FII (Foreign): 19.5%
- DII (Domestic): 19.6%
- Public: 28.2%
Is promoter holding increasing or decreasing in Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 32.7% (Mar 2026)
- Previous Quarter: 32.7% (Dec 2025)
- Change: 0.00% (stable)
How long has Acutaas Chemicals Ltd been outperforming Nifty 500?
Acutaas Chemicals Ltd has been outperforming Nifty 500 for 12 consecutive weeks, indicating strong sustained outperformance.
Is Acutaas Chemicals Ltd a new momentum entry or an established outperformer?
Acutaas Chemicals Ltd is an established outperformer with 12 weeks of consecutive Nifty 500 outperformance.
Is Acutaas Chemicals Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Acutaas Chemicals Ltd may be worth studying
- Earnings growing at +112.7% YoY
- Valuation: appears undervalued
- Cash flow is positive — CFO ₹292 Cr
What is the investment thesis for Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +40.6% YoY
- Appears undervalued
What is the future outlook for Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: stable
- Margin Trend: volatile
- Valuation: Undervalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.